Lantern Pharma (LTRN) Institutional Ownership $3.14 -0.07 (-2.18%) (As of 12/20/2024 05:23 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Lantern Pharma (NASDAQ:LTRN)CurrentInstitutional OwnershipPercentage28.62%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$480.01KNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$232.84K Get LTRN Insider Trade Alerts Want to know when executives and insiders are buying or selling Lantern Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data LTRN Institutional Buying and Selling by Quarter Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Lantern Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/20/2024 Westside Investment Management Inc.30,650$112K0.0%+166.5%0.284% 8/9/2024 Renaissance Technologies LLC81,800$382K0.0%+24.5%0.760% 8/9/2024 Dimensional Fund Advisors LP18,413$86K0.0%+55.7%0.171% 8/2/2024 CM Management LLC80,000$374K0.3%+23.1%0.743% 7/17/2024 Westside Investment Management Inc.11,500$54K0.0%N/A0.107% 5/14/2024 CM Management LLC65,000$572K0.5%-18.8%0.604% Get the Latest News and Ratings for LTRN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lantern Pharma and its competitors with MarketBeat's FREE daily newsletter. 5/10/2024 Tocqueville Asset Management L.P.19,000$167K0.0%N/A0.177% 4/10/2024 Pathway Financial Advisors LLC25,001$220K0.1%-12.3%0.233% 2/12/2024 Redmond Asset Management LLC40,662$174K0.1%-12.6%0.374% 2/8/2024 Meridian Wealth Management LLC19,660$84K0.0%+18.0%0.181% 2/1/2024 Sigma Planning Corp11,875$51K0.0%-34.5%0.109% 2/1/2024 Pathway Financial Advisors LLC28,501$122K0.0%-13.0%0.262% 10/30/2023 Pathway Financial Advisors LLC32,771$112K0.0%+134.1%0.302% 10/17/2023 Meridian Wealth Management LLC16,660$57K0.0%N/A0.153% 8/10/2023 Carlson Capital L P95,000$536K0.0%-23.9%0.875% 8/4/2023 CM Management LLC75,000$423K0.4%+25.0%0.691% 7/19/2023 Pathway Financial Advisors LLC14,001$79K0.0%N/A0.129% 2/9/2023 CM Management LLC60,000$362K0.4%+20.0%0.552% 2/9/2023 Wolff Wiese Magana LLC27,098$164K0.1%-11.0%0.250% 2/7/2023Lynwood Capital Management Inc.12,000$73K0.1%N/A0.110% 11/15/2022 Carlson Capital L P168,000$803K0.1%-1.2%1.547% 11/4/2022 CM Management LLC50,000$239K0.3%+10.9%0.462% 8/8/2022 CM Management LLC45,100$258K0.3%+33.6%0.416% 7/15/2022 Wolff Wiese Magana LLC31,575$180K0.1%-12.7%0.292% 7/11/2022 Sanders Morris Harris LLC366,030$2.06M0.5%-4.7%3.379% 5/9/2022 CM Management LLC33,765$241K0.2%N/A0.312% 5/9/2022 Wolff Wiese Magana LLC36,155$259K0.2%+5.9%0.334% 4/11/2022 Sanders Morris Harris LLC384,228$2.75M0.5%+14.2%3.564% 2/4/2022 Envestnet Asset Management Inc.10,542$84K0.0%N/A0.094% 2/4/2022 Redmond Asset Management LLC49,187$393K0.1%+3.7%0.440% 2/3/2022 Advisor Group Holdings Inc.5,331$43K0.0%+92.5%0.048% 2/2/2022 Sanders Morris Harris LLC336,425$2.57M0.4%N/A3.007% 2/2/2022 Sigma Planning Corp17,600$140K0.0%N/A0.157% 1/14/2022 Spire Wealth Management4,050$32K0.0%+285.7%0.036% 11/9/2021BlackRock Inc.23,074$258K0.0%-8.1%0.206% 11/5/2021 Advisor Group Holdings Inc.2,770$31K0.0%+177.0%0.025% 11/2/2021Raymond James & Associates25,879$289K0.0%N/A0.231% 10/29/2021 GWM Advisors LLC155,859$1.74M0.0%+3.0%1.394% 10/22/2021 Redmond Asset Management LLC47,442$530K0.2%+4.3%0.424% 10/15/2021 Wolff Wiese Magana LLC35,316$395K0.3%+24.7%0.316% We recommended Palantir in 2021, now we’re recommending this... (Ad)My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol8/16/2021Corriente Advisors LLC656,364$9.58M5.2%-8.0%5.869% 8/13/2021 Geode Capital Management LLC55,479$809K0.0%+21.1%0.496% 8/13/2021 Vanguard Group Inc.269,429$3.93M0.0%+4.0%2.409% 8/11/2021 Bank of New York Mellon Corp26,765$391K0.0%+127.3%0.239% 7/31/2021 GWM Advisors LLC151,316$2.21M0.1%N/A1.353% 5/21/2021 Citadel Advisors LLC11,192$203K0.0%N/A0.100% 5/18/2021 Millennium Management LLC42,106$764K0.0%N/A0.377% 5/18/2021 Morgan Stanley50,702$920K0.0%+81.6%0.453% 5/18/2021Corriente Advisors LLC713,806$12.95M4.8%N/A6.384% 5/18/2021 Citadel Advisors LLC11,192$203K0.0%N/A0.100% 5/13/2021 Bank of New York Mellon Corp11,775$213K0.0%N/A0.105% 5/12/2021 Northern Trust Corp12,629$229K0.0%N/A0.113% 5/12/2021 Geode Capital Management LLC45,830$831K0.0%N/A0.410% 5/12/2021 UBS Group AG2,166$39K0.0%N/A0.019% 5/7/2021BlackRock Inc.23,650$429K0.0%+351.2%0.212% 5/6/2021 Redmond Asset Management LLC44,991$816K0.3%N/A0.402% 5/3/2021 Flagship Harbor Advisors LLC147,671$2.68M0.3%N/A1.321% 4/28/2021 US Bancorp DE2,000$36K0.0%N/A0.018% 4/15/2021 Wolff Wiese Magana LLC27,075$491K0.4%N/A0.242% 2/5/2021 CM Management LLC10,000$193K0.2%N/A0.095% 11/13/2020 Morgan Stanley21,384$403K0.0%N/A0.344% 11/6/2020BlackRock Inc.5,009$94K0.0%N/A0.081% (Data available from 1/1/2016 forward) LTRN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of LTRN shares? During the previous two years, 12 institutional investors and hedge funds held shares of Lantern Pharma. The most heavily invested institutionals were Carlson Capital L P ($536K), Renaissance Technologies LLC ($382K), CM Management LLC ($374K), Pathway Financial Advisors LLC ($220K), Redmond Asset Management LLC ($174K), Tocqueville Asset Management L.P. ($167K), and Wolff Wiese Magana LLC ($164K).Learn more on LTRN's institutional investors. What percentage of Lantern Pharma stock is owned by institutional investors? 28.62% of Lantern Pharma stock is owned by institutional investors. Learn more on LTRN's institutional investor holdings. Which institutional investors have been buying Lantern Pharma stock? The following institutional investors have purchased Lantern Pharma stock in the last 24 months: CM Management LLC ($40K), Pathway Financial Advisors LLC ($32.77K), Westside Investment Management Inc. ($30.65K), Meridian Wealth Management LLC ($19.66K), Tocqueville Asset Management L.P. ($19K), Renaissance Technologies LLC ($16.10K), and Lynwood Capital Management Inc. ($12K). How much institutional buying is happening at Lantern Pharma? Institutional investors have bought a total of 176,766 shares in the last 24 months. This purchase volume represents approximately $897.28K in transactions. Which Lantern Pharma major shareholders have been selling company stock? The following institutional investors have sold Lantern Pharma stock in the last 24 months: Carlson Capital L P ($29.90K), CM Management LLC ($15K), Pathway Financial Advisors LLC ($7.77K), Sigma Planning Corp ($6.25K), Redmond Asset Management LLC ($5.84K), and Wolff Wiese Magana LLC ($3.36K). How much institutional selling is happening at Lantern Pharma? Institutional investors have sold a total of 68,128 shares in the last 24 months. This volume of shares sold represents approximately $421.79K in transactions. Related Companies ADAP Major Shareholders PBYI Major Shareholders ELUT Major Shareholders TIL Major Shareholders BDTX Major Shareholders GALT Major Shareholders CGEN Major Shareholders TELO Major Shareholders ATOS Major Shareholders ENTA Major Shareholders This page (NASDAQ:LTRN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lantern Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lantern Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
